MDA SPACE LTD (MDA.CA) Fundamental Analysis & Valuation

TSX:MDA • CA55293N1096

Current stock price

37.85 CAD
+1.84 (+5.11%)
Last:

This MDA.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MDA.CA Profitability Analysis

1.1 Basic Checks

  • In the past year MDA was profitable.
  • In the past year MDA had a positive cash flow from operations.
  • In the past 5 years MDA has always been profitable.
  • MDA had a positive operating cash flow in each of the past 5 years.
MDA.CA Yearly Net Income VS EBIT VS OCF VS FCFMDA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • MDA has a worse Return On Assets (3.23%) than 69.23% of its industry peers.
  • With an excellent Return On Equity value of 8.01%, MDA belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 5.52%, MDA is doing worse than 61.54% of the companies in the same industry.
  • MDA had an Average Return On Invested Capital over the past 3 years of 4.56%. This is below the industry average of 9.52%.
  • The last Return On Invested Capital (5.52%) for MDA is above the 3 year average (4.56%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.23%
ROE 8.01%
ROIC 5.52%
ROA(3y)2.85%
ROA(5y)2.05%
ROE(3y)6.45%
ROE(5y)4.45%
ROIC(3y)4.56%
ROIC(5y)3.69%
MDA.CA Yearly ROA, ROE, ROICMDA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • With a Profit Margin value of 6.64%, MDA is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of MDA has grown nicely.
  • MDA has a Operating Margin of 9.66%. This is in the lower half of the industry: MDA underperforms 61.54% of its industry peers.
  • In the last couple of years the Operating Margin of MDA has declined.
  • MDA has a better Gross Margin (25.09%) than 69.23% of its industry peers.
  • In the last couple of years the Gross Margin of MDA has grown nicely.
Industry RankSector Rank
OM 9.66%
PM (TTM) 6.64%
GM 25.09%
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y17.44%
PM growth 5YN/A
GM growth 3Y-11.03%
GM growth 5Y9.6%
MDA.CA Yearly Profit, Operating, Gross MarginsMDA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MDA.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
  • The number of shares outstanding for MDA has been increased compared to 1 year ago.
  • The number of shares outstanding for MDA has been increased compared to 5 years ago.
  • The debt/assets ratio for MDA is higher compared to a year ago.
MDA.CA Yearly Shares OutstandingMDA.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
MDA.CA Yearly Total Debt VS Total AssetsMDA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • MDA has an Altman-Z score of 1.93. This is not the best score and indicates that MDA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • MDA has a better Altman-Z score (1.93) than 84.62% of its industry peers.
  • The Debt to FCF ratio of MDA is 3.11, which is a good value as it means it would take MDA, 3.11 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.11, MDA belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
  • MDA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • MDA's Debt to Equity ratio of 0.29 is fine compared to the rest of the industry. MDA outperforms 76.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.11
Altman-Z 1.93
ROIC/WACC0.64
WACC8.66%
MDA.CA Yearly LT Debt VS Equity VS FCFMDA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • MDA has a Current Ratio of 0.47. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MDA's Current ratio of 0.47 is on the low side compared to the rest of the industry. MDA is outperformed by 84.62% of its industry peers.
  • A Quick Ratio of 0.45 indicates that MDA may have some problems paying its short term obligations.
  • MDA's Quick ratio of 0.45 is on the low side compared to the rest of the industry. MDA is outperformed by 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.45
MDA.CA Yearly Current Assets VS Current LiabilitesMDA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. MDA.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 88.57% over the past year.
  • Measured over the past years, MDA shows a very strong growth in Earnings Per Share. The EPS has been growing by 81.71% on average per year.
  • MDA shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.21%.
  • The Revenue has been growing by 40.76% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)88.57%
EPS 3Y81.71%
EPS 5YN/A
EPS Q2Q%73.08%
Revenue 1Y (TTM)51.21%
Revenue growth 3Y36.57%
Revenue growth 5Y40.76%
Sales Q2Q%44%

3.2 Future

  • Based on estimates for the next years, MDA will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.39% on average per year.
  • The Revenue is expected to grow by 11.69% on average over the next years. This is quite good.
EPS Next Y14.58%
EPS Next 2Y14.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.07%
Revenue Next 2Y12.84%
Revenue Next 3Y11.69%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MDA.CA Yearly Revenue VS EstimatesMDA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
MDA.CA Yearly EPS VS EstimatesMDA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. MDA.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 28.67, MDA can be considered very expensive at the moment.
  • MDA's Price/Earnings is on the same level as the industry average.
  • MDA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.17, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 25.03, MDA can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, MDA is valued a bit more expensive than 61.54% of the companies in the same industry.
  • MDA's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.05.
Industry RankSector Rank
PE 28.67
Fwd PE 25.03
MDA.CA Price Earnings VS Forward Price EarningsMDA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit more expensive than 69.23% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, MDA is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 36.24
EV/EBITDA 16.91
MDA.CA Per share dataMDA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • MDA's earnings are expected to grow with 14.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.97
PEG (5Y)N/A
EPS Next 2Y14.39%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MDA.CA Dividend Analysis

5.1 Amount

  • No dividends for MDA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDA.CA Fundamentals: All Metrics, Ratios and Statistics

MDA SPACE LTD

TSX:MDA (4/2/2026, 7:00:00 PM)

37.85

+1.84 (+5.11%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners37.75%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap4.79B
Revenue(TTM)1.63B
Net Income(TTM)108.50M
Analysts80
Price Target55.15 (45.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-40.3%
Max EPS beat(2)13%
EPS beat(4)3
Avg EPS beat(4)3.98%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)11.19%
EPS beat(12)10
Avg EPS beat(12)26.46%
EPS beat(16)13
Avg EPS beat(16)60.97%
Revenue beat(2)2
Avg Revenue beat(2)3.42%
Min Revenue beat(2)0.35%
Max Revenue beat(2)6.49%
Revenue beat(4)3
Avg Revenue beat(4)3.37%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)6.87%
Revenue beat(8)6
Avg Revenue beat(8)3.52%
Revenue beat(12)9
Avg Revenue beat(12)2.95%
Revenue beat(16)12
Avg Revenue beat(16)2.63%
PT rev (1m)14.44%
PT rev (3m)35.37%
EPS NQ rev (1m)-10.68%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.76%
Revenue NQ rev (1m)0.37%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)2.01%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE 28.67
Fwd PE 25.03
P/S 2.93
P/FCF 36.24
P/OCF 11.75
P/B 3.53
P/tB N/A
EV/EBITDA 16.91
EPS(TTM)1.32
EY3.49%
EPS(NY)1.51
Fwd EY4%
FCF(TTM)1.04
FCFY2.76%
OCF(TTM)3.22
OCFY8.51%
SpS12.91
BVpS10.71
TBVpS-2.55
PEG (NY)1.97
PEG (5Y)N/A
Graham Number17.84
Profitability
Industry RankSector Rank
ROA 3.23%
ROE 8.01%
ROCE 7.74%
ROIC 5.52%
ROICexc 5.97%
ROICexgc 53.8%
OM 9.66%
PM (TTM) 6.64%
GM 25.09%
FCFM 8.09%
ROA(3y)2.85%
ROA(5y)2.05%
ROE(3y)6.45%
ROE(5y)4.45%
ROIC(3y)4.56%
ROIC(5y)3.69%
ROICexc(3y)4.93%
ROICexc(5y)3.95%
ROICexgc(3y)28.38%
ROICexgc(5y)20.74%
ROCE(3y)6.39%
ROCE(5y)5.17%
ROICexgc growth 3Y61.99%
ROICexgc growth 5YN/A
ROICexc growth 3Y16.02%
ROICexc growth 5YN/A
OM growth 3Y-6%
OM growth 5YN/A
PM growth 3Y17.44%
PM growth 5YN/A
GM growth 3Y-11.03%
GM growth 5Y9.6%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.11
Debt/EBITDA 1.31
Cap/Depr 195.88%
Cap/Sales 16.86%
Interest Coverage 10.52
Cash Conversion 136.56%
Profit Quality 121.75%
Current Ratio 0.47
Quick Ratio 0.45
Altman-Z 1.93
F-Score5
WACC8.66%
ROIC/WACC0.64
Cap/Depr(3y)221.3%
Cap/Depr(5y)203.76%
Cap/Sales(3y)19.79%
Cap/Sales(5y)21.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.57%
EPS 3Y81.71%
EPS 5YN/A
EPS Q2Q%73.08%
EPS Next Y14.58%
EPS Next 2Y14.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.21%
Revenue growth 3Y36.57%
Revenue growth 5Y40.76%
Sales Q2Q%44%
Revenue Next Year13.07%
Revenue Next 2Y12.84%
Revenue Next 3Y11.69%
Revenue Next 5YN/A
EBIT growth 1Y47.75%
EBIT growth 3Y28.37%
EBIT growth 5YN/A
EBIT Next Year118.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.51%
FCF growth 3YN/A
FCF growth 5Y25.11%
OCF growth 1Y-50.04%
OCF growth 3Y92.64%
OCF growth 5Y48.51%

MDA SPACE LTD / MDA.CA Fundamental Analysis FAQ

What is the fundamental rating for MDA stock?

ChartMill assigns a fundamental rating of 4 / 10 to MDA.CA.


Can you provide the valuation status for MDA SPACE LTD?

ChartMill assigns a valuation rating of 1 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Overvalued.


How profitable is MDA SPACE LTD (MDA.CA) stock?

MDA SPACE LTD (MDA.CA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for MDA stock?

The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 28.67 and the Price/Book (PB) ratio is 3.53.


Can you provide the expected EPS growth for MDA stock?

The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 14.58% in the next year.